Davenport & CO LLC Enovis Corp Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Enovis Corp stock. As of the latest transaction made, Davenport & CO LLC holds 2,625,125 shares of ENOV stock, worth $119 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

2,625,125

Previous 2,316,112 13.34%

Holding current value

$119 Million

Previous $105 Million 7.95%

% of portfolio

0.67%

Previous 0.66%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$40.57 - $48.1 $12.5 Million - $14.9 Million	309,013 Added 13.34%	2,625,125 $113 Million
Q2 2024 Aug 06, 2024	BUY	$44.56 - $62.43 $14.9 Million - $20.8 Million	333,660 Added 16.83%	2,316,112 $105 Million
Q1 2024 May 03, 2024	BUY	$55.44 - $63.8 $5.71 Million - $6.57 Million	103,027 Added 5.48%	1,982,452 $124 Million
Q4 2023 Jan 23, 2024	BUY	$43.67 - $57.07 $9.19 Million - $12 Million	210,358 Added 12.6%	1,879,425 $105 Million
Q3 2023 Oct 17, 2023	BUY	$51.65 - $65.54 $17.9 Million - $22.7 Million	346,894 Added 26.24%	1,669,067 $88 Million
Q2 2023 Jul 20, 2023	BUY	$52.7 - $64.12 $26.9 Million - $32.7 Million	509,904 Added 62.78%	1,322,173 $84.8 Million
Q1 2023 Apr 27, 2023	BUY	$49.5 - $65.92 $3.53 Million - $4.7 Million	71,351 Added 9.63%	812,269 $43.4 Million
Q4 2022 Jan 20, 2023	BUY	$44.83 - $57.43 $1.83 Million - $2.34 Million	40,760 Added 5.82%	740,918 $0
Q3 2022 Oct 11, 2022	BUY	$46.07 - $60.1 $3.42 Million - $4.46 Million	74,209 Added 11.86%	700,158 $32.3 Million
Q2 2022 Jul 18, 2022	BUY	$55.0 - $70.47 $34.4 Million - $44.1 Million	625,949 New	625,949 $34.4 Million

Others Institutions Holding ENOV

# of Institutions

311

Shares Held

60.3M

Call Options Held

1.68M

Put Options Held

693K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.45B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account